Status:
UNKNOWN
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH
Lead Sponsor:
Technical University of Munich
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
SARS-CoV2 has become a pandemic disease putting an enormous burden on health care systems around the world. A considerable amount of patients require intensive care treatment for Covid-19 associated p...
Detailed Description
SARS-CoV2 has become a pandemic disease putting an enormous burden on health care systems around the world. The course of disease is relatively mild in most of the patients, but there is a considerabl...
Eligibility Criteria
Inclusion
- Age \> 17a
- diagnosis of SARS CoV 2 by PCR testing
- Hospitalized due to clinical severity of the disease
- written and informed consent or consent of the family
- GFR\<30 is not an exclusion criterion
Exclusion
- not fulfilling the inclusion criteria
- missing written and informed consent
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04347460
Start Date
March 27 2020
End Date
August 31 2020
Last Update
April 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of nephrology, Klinikum rechts der Isar
München, Bavaria, Germany, 81675